This is the second presentation from our “Safe Prescribing during COVID” series.
‘Risk before you leap’: Navigating drug-drug interactions between commonly used psychotropics and off-label/experimental COVID-19 drugs.
DR. SAUMIL DHOLAKIA MBBS, MD, PGD, MHSc
Dr. Saumil Dholakia is a clinical fellow in Geriatric Psychopharmacology and Geriatric Psychiatry at Department of Psychiatry and Behavioral Sciences, McMaster University and GeriMedRisk. Previously, Saumil has worked as a consultant psychiatrist for 10 years with Christian Medical College, Vellore. He is a Bioethicist with a Post-graduate Diploma from Bharathiar University Coimbatore and a Master’s degree from the Joint Center of Bioethics, University of Toronto. His areas of interests are pharmacogenomics in older adults, pharmacologically informed clinical decision-making, deprescribing ethics and MAiD in people with Dementia.
GeriMedRisk-Geriatric Clinical Pharmacology Rounds is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada
Complete your anonymous presenter evaluation here. To receive Royal College of Physicians and Surgeons of Canada credits, please confirm your attendance here.